The Food and Drug Administration (FDA) has updated its warning to the public about a counterfeit version of the over-the-counter weight loss drug Alli 60 mg capsules (120-count refill pack) that is being sold over the Internet, particularly at online auction sites. The new warning includes information from additional laboratory tests that shows that some capsules contain as much as three times the usual daily dose (or twice the recommended maximum dose) of sibutramine, an FDA-approved ingredient for weight loss that can be life-threatening to some populations.

A counterfeit and potentially harmful version of the popular weight loss drug Alli has been found on the Internet, and Food and Drug Administration (FDA) is warning consumers and healthcare providers to be on the look out for it. The drug in question is Alli 60 mg capsules (120-count refill kit). This counterfeit version contains the controlled substance sibutramine and did not contain orlistat, the active ingredient in Alli. Sibutramine is a drug that should be used under physician supervision and should not be used among some individuals as it can interact in a harmful way with other medications.

In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is voluntarily recalling certain lots of OTC products in the Americas, the United Arab Emirates (UAE), and Fiji (FULL RECALLED PRODUCT LIST BELOW). The company is initiating this recall following an investigation of consumer reports of an unusual moldy, musty, or mildew-like odor that, in a small number of cases, was associated with temporary and non-serious gastrointestinal events. These include nausea, stomach pain, vomiting, or diarrhea. This precautionary action is voluntary and has been taken in consultation with the FDA.

Today Graco's Children Products Inc. announced it is recalling 1.5 million strollers due to a hazard of fingertip amputation and laceration. Stroller models affected by this recall include the Graco's Passage, Alano and Spree Strollers and Travel Systems.

A Southern California meat-packing firm has recalled approximately 864,000 pounds of ground-beef that may have been contaminated with E. coli, according to the U.S. Department of Agriculture¹s Food Safety and Inspection Service (FSIS).

A catheter used for various treatments at medical facilities has been recalled by the Food and Drug Administration (FDA) as part of a Class 1 recall. A class 1 recall is the most serious type of action issued by the FDA and involves situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.

All product lots of Tylenol Arthritis Pain Caplet 100-count bottles with the distinctive red EZ-OPEN CAP are being recalled after reports from consumers of an unusual moldy, musty or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea, according to the Food and Drug Administration (FDA). The recall follows a similar recall in November 2009 of only five lots of the product due to similar consumer reports.

The U.S. Consumer Product Safety Commission (CPSC) recalled about 700,000 packages of Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps because the packaging is not child-resistant and lacks the statement "This Package for Households Without Young Children," as required by the Poison Prevention Packaging Act. The medicine in the Vicks Dayquil Cold & Flu medicine contains acetaminophen and could cause serious health problems or death to a child if several of the capsules are swallowed.

Nearly half a million infant car seat / child carriers manufactured by Dorel Juvenile Group, Inc. have been recalled following reports that the handle on the units loosened and detached, causing some infants to suffer fall-related injuries. The U.S. Consumer Products Safety Commission (www.cpsc.gov), the National Highway Traffic Safety Administration (www.nhtsa.gov), and the manufacturer announced the recall on Friday.

The Centers for disease Control (CDC) has recalled 800,000 pre-filled injectable H1N1 vaccines designated for children between 6 months and 35 months old because the agent in the vaccine that produces the immune response to the virus is not as potent as was desired, according to WBRC-TV in Birmingham, Ala.